Pharmaceutical companies, such as AstraZeneca, Novo Nordisk and Roche, are joining the race towards the quantum computing revolution in the industry.
This technology promises to drastically reduce the time for drug research and development, which currently takes a decade on average, to just a few microseconds. Accenture Labs is also collaborating on projects that use quantum computing for personalized diagnosis and therapy, although ethical and regulatory concerns are being raised.
Companies such as Merck, Fujitsu and other leaders in quantum technology, such as IBM, Google and Amazon, are exploring applications ranging from optimizing clinical trials to improving supply chains and creating semiconductor materials for these computers.
In addition, quantum solutions are being researched that manage operating rooms more efficiently and that promise to revolutionize healthcare in the near future.
Quantum computing is gaining ground in the pharmaceutical industry, offering significant potential to accelerate medical research and improve patient care. Large companies and organizations are collaborating in this advance, although technical and ethical challenges must be addressed as this innovative technology is developed and adopted.
Information from: CincoDías.
Receive all industry news in our weekly newsletter Dialectic Science.